HealthEquity Inc (HQY)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $8.56B
Last updated: Nov 17, 2026 at 4:15 PM ET
HealthEquity Inc (HQY) Statistics
HealthEquity (HQY) has a market cap of $8.56B and an enterprise value of $9.26B. Its trailing P/E of 25.0x is below its 10-year median of 40.5x. Its share count is down 3.67% from a year earlier.
Total Valuation
Enterprise value is 8.24% above the market cap, as debt exceeds cash.
| Market Cap | $8.56B |
|---|---|
| Enterprise Value | $9.26B |
| Latest price (Nov 17, 2026) | $101.84 |
Key Dates
The next earnings report is set for Dec 1, 2026, after the close.
| Next Earnings Date | Dec 1, 2026, after the close |
|---|---|
| Last Earnings Date | Aug 27, 2026 |
| Fiscal Year End | January |
Valuation Ratios
Sales and book value multiples are 6.2x and 4.3x. Its year-end P/E ranged from 24.4x to 81.0x from 2016 to 2025.
| P/E Ratio | 25.0x |
|---|---|
| Forward P/E | 21.3x |
| P/S Ratio | 6.2x |
| Forward P/S | 6.0x |
| P/B Ratio | 4.3x |
| P/FCF Ratio | 19.4x |
| P/OCF Ratio | 17.5x |
| PEG Ratio | 1.7 |
Enterprise Valuation
Counting debt and cash, the company is valued at 17.7x EBITDA and 21.0x free cash flow.
| EV / Earnings | 39.2x |
|---|---|
| EV / Sales | 6.8x |
| EV / EBITDA | 17.7x |
| EV / EBIT | 25.6x |
| EV / FCF | 21.0x |
Price Statistics
The stock is up 0.07% over 52 weeks and trades 5.62% above its 50-day average.
| Beta (1Y) | 0.45 |
|---|---|
| 52-Week Change | +0.07% |
| 1-Month Change | +9.42% |
| 3-Month Change | -2.03% |
| 6-Month Change | +20.31% |
| 5-Year Change | +54.84% |
| 10-Year Change | +208.37% |
| Total Return (1Y) | +0.07% |
| Total Return (3Y CAGR) | +14.80% |
| Total Return (5Y CAGR) | +10.13% |
| Return vs SPY (1Y) | -12.44% |
| Max Drawdown (1Y) | -30.57% |
| Max Drawdown (3Y) | -36.07% |
| Sharpe Ratio (1Y) | -0.02 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $96.42 |
| 200-Day Average | $90.13 |
| 52-Week Range | $72.76 to $110.26 |
| RSI (14 Days) | 52.7 |
| Average Volume (20 Days) | 833.93K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.99x current liabilities, and total debt is 0.48x shareholder equity.
| Current Ratio | 2.99x |
|---|---|
| Quick Ratio | 2.99x |
| Debt / Equity | 0.48x |
| Debt / EBITDA | 1.85x |
| Debt / FCF | 2.20x |
| Interest Coverage | 6.88x |
Returns and Efficiency
Return on invested capital is 9.38% over the last 12 months, against a 5-year average of 2.64%.
| Return on Equity (ROE) | 11.88% |
|---|---|
| Return on Assets (ROA) | 7.23% |
| Return on Invested Capital (ROIC) | 9.38% |
| Return on Capital Employed (ROCE) | 11.59% |
| ROE (5Y Average) | 2.75% |
| ROA (5Y Average) | 1.73% |
| ROIC (5Y Average) | 2.64% |
| Asset Turnover | 0.41x |
| Receivables Turnover | 11.16x |
Taxes
Income tax took 23.39% of pretax income over the last 12 months.
| Income Tax (TTM) | $72.22M |
|---|---|
| Effective Tax Rate | 23.39% |
Scores
HQY has an Altman Z-Score of 4.94, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.94 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 9 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $1.36B over the last 12 months is up 7.34% from the 12 months before.
| Revenue | $1.36B |
|---|---|
| Revenue Growth (YoY) | +7.34% |
| Gross Profit | $970.48M |
| Operating Income | $351.41M |
| Pretax Income | $308.71M |
| Net Income | $236.49M |
| EBITDA | $519.77M |
| EBIT | $361.22M |
| Reported EPS (TTM) | $4.07 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 60.86% of the $3.27B in total assets.
| Cash and Equivalents | $256.00M |
|---|---|
| Total Debt | $961.05M |
| Net Debt | $705.04M |
| Net Debt Per Share | $8.46 |
| Working Capital | $306.43M |
| Shareholder Equity | $1.99B |
| Book Value Per Share | $23.87 |
| Tangible Book Value | -$705.83M |
| Total Assets | $3.27B |
| Total Liabilities | $1.28B |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $53.22M of capital spending, operating cash flow left $436.95M of free cash flow.
| Operating Cash Flow | $490.18M |
|---|---|
| Capital Expenditures | $53.22M |
| Free Cash Flow | $436.95M |
| FCF Per Share | $5.28 |
| Depreciation and Amortization | $158.55M |
| Share Repurchases | $404.50M |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is 25.80%, against a 5-year average of 9.54%.
| Gross Margin | 71.25% |
|---|---|
| Operating Margin | 25.80% |
| Pretax Margin | 22.66% |
| Net Margin | 17.36% |
| EBITDA Margin | 38.16% |
| EBIT Margin | 26.52% |
| FCF Margin | 32.08% |
| Gross Margin (5Y Average) | 61.97% |
| Operating Margin (5Y Average) | 9.54% |
| Net Margin (5Y Average) | 4.23% |
Growth
Revenue grew 15.08% a year over 3 years, and EPS 43.75% a year.
| Revenue Growth (3Y CAGR) | +15.08% |
|---|---|
| Revenue Growth (5Y CAGR) | +12.36% |
| EPS Growth (3Y CAGR) | +43.75% |
| EPS Growth (5Y CAGR) | +19.01% |
| FCF Growth (3Y CAGR) | +58.76% |
| FCF Growth (5Y CAGR) | +28.41% |
| Operating Income Growth (3Y CAGR) | +228.97% |
| Book Value Per Share Growth (2Y CAGR) | +1.74% |
Dividends and Yields
HQY does not pay a dividend. Its free cash flow yield is 5.15%.
| Earnings Yield | 4.00% |
|---|---|
| FCF Yield | 5.15% |
| Buyback Yield | 4.76% |
| Shareholder Yield | 4.76% |
Peer Position
Against 6 similar companies, HQY has the 6th highest P/E and the 3rd highest ROIC.
P/E RatioPeer median 37.9x
P/S RatioPeer median 1.4x
ROICPeer median -7.19%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +16.63%
| P/E Ratio | 25.0x vs 37.9x median |
|---|---|
| P/S Ratio | 6.2x vs 1.4x median |
| ROIC | 9.38% vs -7.19% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +7.34% vs +16.63% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.82% and EPS growth at 17.31% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.82% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +17.31% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HQY
What is HQY's market cap?
HealthEquity has a market cap of $8.56B. Its enterprise value, which adds debt and subtracts cash, is $9.26B.
What is HQY's P/E ratio?
HealthEquity has a trailing P/E ratio of 25.0x and a forward P/E of 21.3x.
How many shares of HQY are outstanding?
HealthEquity has 83.37M shares outstanding. The count is down 3.67% from a year earlier.
Does HQY pay a dividend?
No. HealthEquity does not pay a dividend.
How much debt does HQY have?
HealthEquity has $961.05M of total debt and $256.00M of cash and equivalents, a net debt position of $705.04M.
HQY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts